The popularization of prostate-specific antigen (PSA) screening in the United States since the late 1980s has resulted in the early detection and sometimes over diagnoses of prostate cancer, which would not otherwise have been diagnosed within the patients' lifetime[1]. Here, KLK3 is linked to prostate cancer.